Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300,720 | 175 | 74.8% |
| Consulting Fee | $55,459 | 27 | 13.8% |
| Travel and Lodging | $35,865 | 294 | 8.9% |
| Food and Beverage | $6,186 | 122 | 1.5% |
| Honoraria | $2,000 | 1 | 0.5% |
| Unspecified | $1,658 | 12 | 0.4% |
| Education | $39.95 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $373,729 | 600 | $0 (2024) |
| Ceribell, Inc. | $15,330 | 7 | $0 (2024) |
| Marinus Pharmaceuticals, Inc. | $4,999 | 5 | $0 (2024) |
| Sage Therapeutics, Inc. | $4,095 | 4 | $0 (2023) |
| NATUS MEDICAL INCORPORATED | $2,000 | 1 | $0 (2024) |
| Biogen, Inc. | $1,706 | 13 | $0 (2018) |
| Integra LifeSciences Corporation | $52.03 | 1 | $0 (2017) |
| Lilly USA, LLC | $17.59 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84,583 | 88 | UCB, Inc. ($69,652) |
| 2023 | $82,394 | 134 | UCB, Inc. ($74,838) |
| 2022 | $66,897 | 99 | UCB, Inc. ($63,004) |
| 2021 | $38,217 | 54 | UCB, Inc. ($38,172) |
| 2020 | $49,193 | 72 | UCB, Inc. ($49,193) |
| 2019 | $41,335 | 92 | UCB, Inc. ($41,335) |
| 2018 | $39,231 | 91 | UCB, Inc. ($37,507) |
| 2017 | $79.67 | 2 | Integra LifeSciences Corporation ($52.03) |
All Payment Transactions
632 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | NATUS MEDICAL INCORPORATED | — | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $134.50 | General |
| Category: Neurology | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,200.00 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $52.26 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | Cash or cash equivalent | $33.78 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $29.98 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $23.92 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $22.99 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | Cash or cash equivalent | $8.78 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $159.25 | General |
| 10/02/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | In-kind items and services | $397.95 | General |
| Category: Neurology | ||||||
| 10/02/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | In-kind items and services | $209.79 | General |
| Category: Neurology | ||||||
| 10/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $100.30 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Neurology | ||||||
| 09/10/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,200.00 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $52.26 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $40.83 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $29.87 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $23.00 | General |
| Category: Neurology | ||||||
| 09/05/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $19.91 | General |
| Category: Neurology | ||||||
| 08/29/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | Biogen, Inc. | $1,658 | 12 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 31 | 69 | $44,569 | $11,152 |
| 2022 | 1 | 22 | 70 | $41,774 | $11,275 |
| 2021 | 1 | 20 | 51 | $28,305 | $10,018 |
| 2020 | 1 | 38 | 102 | $56,610 | $18,626 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 69 | $44,569 | $11,152 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 70 | $41,774 | $11,275 | 27.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 20 | 51 | $28,305 | $10,018 | 35.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 38 | 102 | $56,610 | $18,626 | 32.9% |
About Brandon Foreman, MD MS
Brandon Foreman, MD MS is a Critical Care Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477748382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandon Foreman, MD MS has received a total of $401,928 in payments from pharmaceutical and medical device companies, with $84,583 received in 2024. These payments were reported across 632 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($300,720).
As a Medicare-enrolled provider, Foreman has provided services to 111 Medicare beneficiaries, totaling 292 services with total Medicare billing of $51,070. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Neurology, Neurology
- Location Cincinnati, OH
- Active Since 09/13/2007
- Last Updated 03/17/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1477748382
Products in Payments
- Briviact (Drug) $359,253
- POCKET EEG DEVICE (Device) $10,835
- Ceribell Rapid Response EEG (Device) $4,496
- ZTALMY (Drug) $1,935
- Fintepla (Drug) $750.00
- BRIVIACT (Drug) $244.65
- Neuro-Monitoring Catheters and Equipment (Device) $52.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Cincinnati
Mohammad Sheatt, Md, MD
Critical Care Medicine — Payments: $363,450
Joseph Thorpe, Md, MD
Critical Care Medicine — Payments: $22,853
Craig Eisentrout, Md, MD
Critical Care Medicine — Payments: $17,559
Michael Halvonik, Md, MD
Critical Care Medicine — Payments: $12,090
Dr. Ramakanth Pata, M.d, M.D
Critical Care Medicine — Payments: $7,365
Dr. Sunil Dama, M.d, M.D
Critical Care Medicine — Payments: $6,747